These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1406738)

  • 21. Application of flow cytometry and automated image analysis to the study of prostate cancer.
    Benson MC
    NCI Monogr; 1988; (7):25-9. PubMed ID: 3050538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic value of flow cytometry of bladder lavage in the surveillance of bladder tumors].
    Hijazi A; Devonec M; Muchada E; Dubernard JM; Revillard JP
    J Urol (Paris); 1987; 93(1):11-20. PubMed ID: 3559255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathology of the prostate in radical cystectomy specimens: a critical review.
    Autorino R; Di Lorenzo G; Damiano R; Giannarini G; De Sio M; Cheng L; Montironi R
    Surg Oncol; 2009 Mar; 18(1):73-84. PubMed ID: 18760917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prostate involvement as prognostic factor in patients with superficial bladder tumors.
    Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova JL; Almenar S
    J Urol; 1995 Nov; 154(5):1710-3. PubMed ID: 7563328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
    Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
    Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometry.
    Gschwendtner A; Hoffmann-Weltin Y; Mikuz G; Mairinger T
    Mod Pathol; 1999 Aug; 12(8):806-13. PubMed ID: 10463483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphological criteria of the effectiveness of using cryogenic exposure in treating bladder and prostate tumors].
    Romanenko AM; Nosov AT; Mirgorodskaia LN
    Vrach Delo; 1982 Feb; (2):84-6. PubMed ID: 7064463
    [No Abstract]   [Full Text] [Related]  

  • 32. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.
    Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A
    Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transitional cell carcinoma involvement of the prostate].
    Bassi P; De Lisa A; Usai P; Pinto F; Sacco E
    Ann Urol (Paris); 2005 Nov; 39 Suppl 5():S113-9. PubMed ID: 16425728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphometry of bladder carcinoma: I. The automatic delineation of urothelial nuclei in tissue sections using an IBAS II image array processor.
    Sowter C; Slavin G; Rosen D
    J Pathol; 1987 Nov; 153(3):289-97. PubMed ID: 3430233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.
    Herr HW; Donat SM
    J Urol; 1999 Jun; 161(6):1854-7. PubMed ID: 10332452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometry in carcinoma of the prostate.
    Benson MC; Ring K; Giella J
    Urol Clin North Am; 1990 Nov; 17(4):885-91. PubMed ID: 2219584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An image analysis method for assessment of prognostic risk in prostate cancer: a pilot study.
    Stephenson RA; Zahniser DJ; Wong KL; Hutchinson ML
    Anal Cell Pathol; 1991 Jul; 3(4):243-8. PubMed ID: 1883748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography].
    Beer M; Schmidt H; Riedl R
    Urologe A; 1989 Mar; 28(2):65-9. PubMed ID: 2718295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.